4//SEC Filing
Storgard Chris 4
Accession 0001415889-25-014477
CIK 0001807120other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:26 PM ET
Size
5.5 KB
Accession
0001415889-25-014477
Insider Transaction Report
Form 4
Storgard Chris
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2025-05-01+400,000→ 400,000 totalExercise: $4.71Exp: 2035-04-30→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest as follows: 25% of the shares will vest on April 16, 2026 and the balance of the shares will vest in equal monthly installments thereafter over the following 36 months.
Documents
Issuer
Design Therapeutics, Inc.
CIK 0001807120
Entity typeother
Related Parties
1- filerCIK 0001674703
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 4:26 PM ET
- Size
- 5.5 KB